Good evening :)
$
G

Generate Biomedicines, Inc. Common Stock

GENB

NASDAQ
$16.380.25% (+0.04)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Biotechnology

Mid Cap

With a market cap of $2.1B the stock is ranked 2191

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

PB
PB

Close price divided by the book value per share at the end of the most recent quarter

4.59
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-2.1
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

Company Profile

Peers

Peers

P/E Ratio
72.44
72.44
1Y Return
23.04%
23.04%
Buy Reco %
57.14
57.14
P/E Ratio
27.17
27.17
1Y Return
57.21%
57.21%
Buy Reco %
46.87
46.87
P/E Ratio
1Y Return
34.82%
34.82%
Buy Reco %
63.33
63.33
P/E Ratio
31.84
31.84
1Y Return
37.58%
37.58%
Buy Reco %
52.94
52.94
P/E Ratio
20.49
20.49
1Y Return
46.1%
46.1%
Buy Reco %
76.00
76.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Generate Biomedicines, Inc. Common Stock -4.59-
AbbVie Inc72.4450.450.37
Amgen Inc27.1720.542.13

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

8.8
-41.6
10.1
-52.4
7.2
-61.4
6.3
-67.2
Q1 2025
Q2 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2025Q2 2025Q1 2026Q2 2026
Total Revenue8.8110.137.226.31
Net Income-41.68-52.42-61.44-67.25
Net Profit Margin-472.72%-517.56%-850.58%-1065.17%

Frequently asked questions

Frequently asked questions

  1. Generate Biomedicines, Inc. Common Stock (GENB) share price today is $16.38 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $16.59 and a day low of $16.01.

  2. Generate Biomedicines, Inc. Common Stock stock trades on NASDAQ under the ticker symbol GENB.

  3. Generate Biomedicines, Inc. Common Stock's market capitalization is $2.1B as of September 5, 2026 at 1:30 AM IST.

  4. Generate Biomedicines, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of September 7, 2026.

  5. Generate Biomedicines, Inc. Common Stock's price-to-book (P/B) ratio is 4.59 as of September 7, 2026.

  6. Yes, You can buy Generate Biomedicines, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Generate Biomedicines, Inc. Common Stock shares in three steps: 1. Search Generate Biomedicines, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Generate Biomedicines, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Generate Biomedicines, Inc. Common Stock (GENB) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.6104 shares at the current price of $16.38.

Loading...